Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aethlon Medical

1.82
+0.246415.69%
Volume:220.29K
Turnover:382.03K
Market Cap:3.65M
PE:-0.23
High:1.88
Open:1.58
Low:1.57
Close:1.57
Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Yesterday

Aethlon Medical Inc expected to post a loss of $1.01 a share - Earnings Preview

Reuters
·
25 Jun

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
23 Jun

Aethlon Medical Inc. to Announce Fiscal Fourth Quarter Financial Results

Reuters
·
20 Jun

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
20 Jun

Aethlon treats second patient with Hemopurifier in Australian clinical trial

TIPRANKS
·
18 Jun

Aethlon Medical Inc. Announces Progress in Hemopurifier® Cancer Trial with Second Patient Treated in Australia

Reuters
·
18 Jun

Aethlon Medical Announces New Pre-Clinical Data on Hemopurifier® for Long COVID at Keystone Symposium

Reuters
·
09 Jun

Aethlon Medical trading halted, news pending

TIPRANKS
·
07 Jun

Aethlon Medical Approves Reverse Stock Split Plan

TIPRANKS
·
05 Jun

Aethlon Medical Inc. Announces 1-for-8 Reverse Stock Split Effective June 9, 2025

Reuters
·
05 Jun

Aethlon Medical Inc. Announces New Clinical Study Highlighting Hemopurifier's Ability to Remove Platelet-Derived Extracellular Vesicles in Ongoing Oncology Trial

Reuters
·
14 May

Aethlon Medical Approves Key Stockholder Proposals

TIPRANKS
·
14 May

Aethlon Medical Inc. Conducted Special Stockholders Meeting Virtually

Reuters
·
14 May

Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now

GlobeNewswire
·
26 Mar

Aethlon Medical Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Mar

Buy Rating for Aethlon Medical Driven by Hemopurifier’s Potential in Organ Transplantation and Projected Growth

TIPRANKS
·
10 Mar

Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

PR Newswire
·
10 Mar

Aethlon Medical Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
19 Feb

Q3 2025 Aethlon Medical Inc Earnings Call

Thomson Reuters StreetEvents
·
14 Feb